Quantitative Label-Free Proteomics for Discovery of Biomarkers in Cerebrospinal Fluid: Assessment of Technical and Inter-Individual Variation

BACKGROUND: Biomarkers are required for pre-symptomatic diagnosis, treatment, and monitoring of neurodegenerative diseases such as Alzheimer's disease. Cerebrospinal fluid (CSF) is a favored source because its proteome reflects the composition of the brain. Ideal biomarkers have low technical a...

Descripción completa

Detalles Bibliográficos
Autores principales: Perrin, Richard J., Payton, Jacqueline E., Malone, James P., Gilmore, Petra, Davis, Alan E., Xiong, Chengjie, Fagan, Anne M., Townsend, R. Reid, Holtzman, David M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659127/
https://www.ncbi.nlm.nih.gov/pubmed/23700471
http://dx.doi.org/10.1371/journal.pone.0064314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659127/
https://www.ncbi.nlm.nih.gov/pubmed/23700471
http://dx.doi.org/10.1371/journal.pone.0064314

Ejemplares similares